St Paul Hospital

Vancouver V6Z 1Y6

2 studies enrolling now · 2 studies all time

What they study most

End Stage Kidney Disease, Tricuspid Regurgitation

Studies at this site

• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• Outcome of Patients With Severe Functional TR According to Medical, Transcatheter or Surgical Treatment — Enrolling by invitation